RESULTS	The addition of sitagliptin led to significant ( P < .001 ) mean changes from baseline relative to placebo in HbA1c ( -0.7 % ) , fasting plasma glucose ( -1.0 mmol/L ) , and 2-h post-meal glucose ( -2.2 mmol/L ) .\